Charles Schwab’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-5,033
| Closed | -$135K | – | 3298 |
|
2019
Q1 | $135K | Sell |
5,033
-2,743
| -35% | -$73.6K | ﹤0.01% | 3067 |
|
2018
Q4 | $176K | Buy |
7,776
+1,965
| +34% | +$44.5K | ﹤0.01% | 3033 |
|
2018
Q3 | $321K | Sell |
5,811
-7,971
| -58% | -$440K | ﹤0.01% | 2988 |
|
2018
Q2 | $984K | Buy |
13,782
+1,167
| +9% | +$83.3K | ﹤0.01% | 2590 |
|
2018
Q1 | $775K | Buy |
12,615
+422
| +3% | +$25.9K | ﹤0.01% | 2599 |
|
2017
Q4 | $1.54M | Buy |
12,193
+1,339
| +12% | +$169K | ﹤0.01% | 2393 |
|
2017
Q3 | $1.49M | Buy |
10,854
+4,370
| +67% | +$598K | ﹤0.01% | 2392 |
|
2017
Q2 | $925K | Buy |
6,484
+44
| +0.7% | +$6.28K | ﹤0.01% | 2481 |
|
2017
Q1 | $1.18M | Buy |
6,440
+393
| +6% | +$72.3K | ﹤0.01% | 2376 |
|
2016
Q4 | $488K | Buy |
6,047
+354
| +6% | +$28.6K | ﹤0.01% | 2655 |
|
2016
Q3 | $437K | Buy |
5,693
+20
| +0.4% | +$1.54K | ﹤0.01% | 2659 |
|
2016
Q2 | $488K | Buy |
5,673
+93
| +2% | +$8K | ﹤0.01% | 2595 |
|
2016
Q1 | $517K | Buy |
5,580
+112
| +2% | +$10.4K | ﹤0.01% | 2566 |
|
2015
Q4 | $1.1M | Sell |
5,468
-1,131
| -17% | -$227K | ﹤0.01% | 2354 |
|
2015
Q3 | $985K | Buy |
6,599
+3,716
| +129% | +$555K | ﹤0.01% | 2388 |
|
2015
Q2 | $2.74M | Buy |
2,883
+733
| +34% | +$696K | ﹤0.01% | 1917 |
|
2015
Q1 | $1.58M | Buy |
2,150
+280
| +15% | +$205K | ﹤0.01% | 2182 |
|
2014
Q4 | $1.49M | Buy |
1,870
+255
| +16% | +$203K | ﹤0.01% | 2168 |
|
2014
Q3 | $645K | Hold |
1,615
| – | – | ﹤0.01% | 2496 |
|
2014
Q2 | $436K | Buy |
1,615
+480
| +42% | +$130K | ﹤0.01% | 2683 |
|
2014
Q1 | $248K | Buy |
1,135
+315
| +38% | +$68.8K | ﹤0.01% | 2878 |
|
2013
Q4 | $222K | Hold |
820
| – | – | ﹤0.01% | 2927 |
|
2013
Q3 | $194K | Hold |
820
| – | – | ﹤0.01% | 2924 |
|
2013
Q2 | $120K | Buy |
+820
| New | +$120K | ﹤0.01% | 3011 |
|